Table 1.
CD117 expression in renal tumours
| Age | Grade | Intensity | Extent | Score |
| Conventional RCCs | ||||
| 61 | III | 0 | ||
| 58 | IV | 0 | ||
| 47 | II | 0 | ||
| 66 | III | 0 | ||
| 38 | II | 0 | ||
| 45 | II | 0 | ||
| 77 | II | 0 | ||
| 80 | II | 0 | ||
| 73 | III | 0 | ||
| 70 | IV | 0 | ||
| 72 | III | 3 | 2 | 5 |
| 75 | III | 0 | ||
| 69 | IV | 2 | 1 | 3 |
| Papillary RCCs | ||||
| 61 | II | 0 | ||
| 60 | III | 0 | ||
| 63 | II | 0 | ||
| 64 | II | 0 | ||
| 69 | III | 1 | 2 | 3 |
| 55 | III | 2 | 2 | 4 |
| 45 | II | 0 | ||
| Chromophobe RCCs | ||||
| 51 | III | 2 | 2 | 4 |
| 55 | II | 0 | ||
| 53 | II | 0 | ||
| 59 | II | 1 | 4 | 5 |
| 60 | II | 1 | 2 | 3 |
| 48 | II | 0 | ||
| 87 | III | 1 | 4 | 5 |
| Nephroblastomas | ||||
| 7 | 0 | |||
| 10 | 0 | |||
| 5 | 0 | |||
| 5 | 0 | |||
| 6 | 0 | |||
| 5 | 0 | |||
| Oncocytomas | ||||
| 57 | 3 | 4 | 7 | |
| 73 | 2 | 4 | 6 | |
| 43 | 1 | 4 | 5 | |
| 77 | 1 | 3 | 4 | |
| 64 | 3 | 4 | 7 | |
| 68 | 2 | 3 | 5 | |
| 61 | 3 | 4 | 7 | |
| Mesoblastic nephromas | ||||
| 5 days | 2 | 3 | 5 | |
| 3 months | 3 | 2 | 5 | |
| Angiomyolipomas | ||||
| 50 | 0 | |||
| 46 | 0 | |||
| 68 | 2 | 1 | 3 | |
| 32 | 2 | 1 | 3 | |
Age is in years unless otherwise specified.
RCC, renal cell carcinoma.